News

News

  • Home
  • News
  • Introducing Innovative Hematology/IHTC’s Cardiovascular Disease (CVD) Risk Reduction Program

Introducing Innovative Hematology/IHTC’s Cardiovascular Disease (CVD) Risk Reduction Program

Jan 27, 2025

Innovative Hematology and the Indiana Hemophilia & Thrombosis Center (IHTC) are excited to announce our new Cardiovascular Disease Risk Reduction Program. Cardiovascular disease (CVD) is also known as heart disease. The goal of this program is to reduce patients’ risk of CVD.

Adult patients (age 18+) seen in comprehensive clinic or another appointment might meet Dr. Kristi Dickson. Dr. Dickson is an internal medicine physician. She will ask questions, do a focused physical exam, and recommend lab tests to help determine patients’ risk of heart disease. She will talk with patients about how to keep their heart and blood vessels healthy and make suggestions to help lower their risk of developing heart disease in the future.

Patients in our CVD program can expect:

  • Personal Care Plan: It’s important to understand each patient’s personal needs and health goals. Dr. Dickson will suggest a personal care plan for these patients to help avoid heart problems.
  • Multidisciplinary Team: Our team will work together to give each patient the complete care they need. Patients will still be able to work with Innovative Hematology/IHTC staff, including:
      • Providers
      • Social workers
      • Career counselors
      • Insurance coordinators
      • Nutritionist
      • Pharmacists
      • Psychologist
      • Physical therapists
  • Patient Education: We will give these patients information to help them understand their condition and make healthy decisions.

Our patients’ health is our top priority. We believe that looking at heart disease risk factors regularly can lead to better health and quality of life.

If you have any questions about the program, please contact us at 317.871.0000.

Our Recent News

Innovative Hematology CEO, Medical Director awarded Lifetime Achievement Award

Innovative Hematology CEO, Medical Director awarded Lifetime Achievement Award

Dr. Amy Shapiro, CEO and co-medical director of Innovative Hematology, home to the Indiana Hemophilia & Thrombosis Center (IHTC)—the state’s only federally designated hemophilia treatment center—has received a lifetime achievement award for her extensive accomplishments in classical hematology.

IN groups advocate for more research, diagnoses for rare illnesses

IN groups advocate for more research, diagnoses for rare illnesses

Support for families and loved ones of individuals with rare diseases is often limited simply because of their lack of familiarity. One such hereditary condition, known as Hereditary Hemorrhagic Telangiectasia or HHT, affects more than 600 Hoosiers, according to the Indiana Hemophilia and Thrombosis Center.

Bleeding Disorders: What You Need to Know

Bleeding Disorders: What You Need to Know

By: Indy's Child Staff For most kids, playground bumps and bruises are no big deal. But for kids with a bleeding disorder like hemophilia or von Willebrand disease (VWD), these injuries—especially to the head—could be an emergency.  What is a bleeding disorder?   A...

Connect

Innovative Hematology, Inc.
8326 Naab Road
Indianapolis, IN 46260

317-871-0000
877-CLOTTER (877-256-8837)
317-871-0010 (fax)